SUBJECTS' CONSENT FORM Page _6_of_6. 
Appr. Dace: 8/4/94 TITLE: Phase I Trial, of Interleukin-2 Plasmid Number. 
DNA DMRIE/DOPE Lipid Complex as an Lmmuno- SWOG: 
therapeutic Agent in Solid Malignant Tumors HSC:94-129 
or Lymphomas by Direct Gene Transfer(VCL 1 102) 
FILED IN AN AREA DESIGNATED BY THE HUMAN SUBJECTS COMMITTEE WITH 
ACCESS RESTRICTED TO THE PRINCIPAL INVESTIGATORS. EVAN M. HERSH, MD, 
EVAN UNGER, MD, JAMES WARNEKE,MD OR ALISON STOPECK,MD. AN 
AUTHORIZED REPRESENTATIVE OF THE HEMATOLOGY/ONCOLOGY SECTION OF THE 
CANCER CENTER. I UNDERSTAND THAT I DO NOT GIVE UP ANY OF MY LEGAL 
RIGHTS BY SIGNING THIS FORM A COPY OF THIS SIGNED CONSENT FORM WILL BE 
GIVEN TO ME 
SIGNATURES: 
Subject 
Date Parent/Legal Representative Date 
I have carefully explained to the subject the nature of the above project. I 
hereby certify that to the best of my knowledge the person who is signing 
this consent form understands clearly the nature, demands, benefits and risks 
involved in his/her participation. A medical problem or language or 
educational barrier has not precluded this understanding. 
Investigator 
Date Witness 
Date 
Recombinant DNA Research, Volume 20 
[625] 
